181.70

2.52% 4.47

Repligen Corp (RGEN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RGEN? Forum Prognose

Schlusskurs vom Vortag:

$177.23

Offen:

$179.32

24-Stunden-Volumen:

1.46M

Relative Volume:

1.33

Marktkapitalisierung:

$10.25B

Einnahmen:

$763.34M

Nettoeinkommen (Verlust:

$51.40M

KGV:

200.02

EPS:

0.9084

Netto-Cashflow:

$104.46M

1W Leistung:

-4.21%

1M Leistung:

+5.07%

6M Leistung:

+54.27%

1J Leistung:

+25.11%

1-Tages-Spanne:

$178.00

$186.52

1-Wochen-Bereich:

$177.12

$198.87

52-Wochen-Spanne:

$100.99

$198.87

Repligen Corp Stock (RGEN) Company Profile

Firmenname

Repligen Corp

Sektor

Healthcare (1064)

Branche

Medical Instruments & Supplies (56)

Telefon

(781) 449-9560

Adresse

41 SEYON STREET, WALTHAM, MA

Mitarbeiter

2,000

Twitter

@repligen

Nächster Verdiensttermin

2026-10-27

Neueste SEC-Einreichungen

RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, RMD, MDLN, ALC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RGEN Repligen Corp	181.70	10.70B	763.34M	51.40M	104.46M	0.9084
ISRG Intuitive Surgical Inc	391.95	143.14B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	176.80	50.07B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	218.89	32.02B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.61	30.44B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	63.76	31.16B	10.63B	819.00M	1.59B	1.6577

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-09-09	Fortgesetzt	UBS	Buy
2026-07-07	Hochstufung	The Benchmark Company	Hold → Buy
2026-06-02	Fortgesetzt	Wolfe Research	Outperform
2026-05-15	Fortgesetzt	RBC Capital Mkts	Outperform
2026-04-17	Eingeleitet	Rothschild & Co Redburn	Buy
2025-10-01	Eingeleitet	HSBC Securities	Buy
2025-09-22	Hochstufung	Evercore ISI	In-line → Outperform
2025-07-22	Fortgesetzt	Stephens	Overweight
2025-06-24	Eingeleitet	Barclays	Overweight
2025-04-29	Hochstufung	Wolfe Research	Peer Perform → Outperform
2025-03-18	Eingeleitet	Evercore ISI	In-line
2025-02-10	Eingeleitet	TD Cowen	Buy
2024-12-17	Eingeleitet	Canaccord Genuity	Hold
2024-11-14	Eingeleitet	Wolfe Research	Peer Perform
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-06-26	Hochstufung	Deutsche Bank	Hold → Buy
2024-06-18	Eingeleitet	Guggenheim	Neutral
2023-12-04	Herabstufung	The Benchmark Company	Buy → Hold
2023-07-20	Eingeleitet	Wells Fargo	Overweight
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-03-28	Eingeleitet	The Benchmark Company	Buy
2022-12-14	Eingeleitet	Deutsche Bank	Hold
2022-12-07	Eingeleitet	RBC Capital Mkts	Sector Perform
2022-07-20	Eingeleitet	UBS	Buy
2021-10-14	Eingeleitet	Exane BNP Paribas	Outperform
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-08-24	Bestätigt	H.C. Wainwright	Buy
2020-06-30	Bestätigt	H.C. Wainwright	Buy
2020-05-07	Bestätigt	H.C. Wainwright	Buy
2020-03-23	Bestätigt	H.C. Wainwright	Buy
2019-11-15	Eingeleitet	Stifel	Buy
2019-11-01	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2019-10-15	Eingeleitet	SVB Leerink	Outperform
2019-08-28	Bestätigt	First Analysis Sec	Outperform
2019-08-23	Fortgesetzt	Stephens	Overweight
2019-07-22	Hochstufung	H.C. Wainwright	Neutral → Buy
2018-12-17	Hochstufung	CL King	Neutral → Buy
2018-11-12	Herabstufung	CL King	Buy → Neutral
2018-09-26	Eingeleitet	H.C. Wainwright	Neutral
2017-12-08	Eingeleitet	Citigroup	Buy
2017-12-05	Eingeleitet	JP Morgan	Overweight
2017-11-13	Eingeleitet	CL King	Buy
2017-10-02	Hochstufung	First Analysis Sec	Equal-Weight → Overweight
2017-07-21	Eingeleitet	William Blair	Outperform
2017-02-13	Hochstufung	Piper Jaffray	Neutral → Overweight

Alle ansehen

Repligen Corp Aktie (RGEN) Neueste Nachrichten

Oct 01, 2026

Continuous Bioprocessing Technologies Market - GlobeNewswire Inc.

Oct 01, 2026

Sep 30, 2026

Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 30, 2026

Sep 29, 2026

Repligen stock price target reaffirmed at $225 by UBS on growth outlook - Investing.com South Africa

Sep 29, 2026

Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - TradingView

Sep 29, 2026

Sep 28, 2026

Form 4 Repligen Corporation For: 28 September - Investing.com India

Sep 28, 2026

After a stock-unit release, Repligen (RGEN) withheld 421 shares from its CFO to cover taxes. - Stock Titan

Sep 28, 2026

Sep 27, 2026

Repligen CEO Olivier Loeillot sells $976,680 in company stock By Investing.com - Investing.com South Africa

Sep 27, 2026

Form 4 Repligen Corporation For: 27 September By Investing.com - Investing.com Canada

Sep 27, 2026

Repligen CEO Olivier Loeillot sells $976,680 in company stock - Investing.com

Sep 27, 2026

Form 4 Repligen Corporation For: 27 September - Investing.com India

Sep 27, 2026

Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance UK

Sep 27, 2026

Sep 26, 2026

US759916AC3 Bond Profile: Coupon and Redemption - TradingView

Sep 26, 2026

Repligen CEO Loeillot sells $2.46m in shares By Investing.com - Investing.com South Africa

Sep 26, 2026

Form 4 Repligen Corporation For: 26 September By Investing.com - Investing.com India

Sep 26, 2026

Repligen (RGEN) CEO sells shares at $190 each after exercising options under a trading plan. - Stock Titan

Sep 25, 2026

Sep 24, 2026

Form 144 REPLIGEN CORP For: 24 September By Investing.com - Investing.com Nigeria

Sep 24, 2026

Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance

Sep 24, 2026

Is Repligen Corp (RGEN) Overvalued After 3.3% Rally? GF Value Sa - GuruFocus

Sep 24, 2026

Shares valued at $2.46 million are listed for sale by a Repligen (NASDAQ: RGEN) officer and director. - Stock Titan

Sep 24, 2026

Repligen Corp Stock Baskets - GuruFocus

Sep 24, 2026

Sep 23, 2026

Repligen Corp (BSP:R2GE34) Stock Price & 30 Year Financial Data - GuruFocus

Sep 23, 2026

Repligen Corporation stock hits 52-week high at 188.95 USD - Investing.com

Sep 23, 2026